Zobrazeno 1 - 10 of 20 pro vyhledávání: '"Marjo E. E. Van Kasteren"'
1
Akademický článek
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen
Autor: Arjen J. Stam, Ninée V. E. J. Buchholtz, Wouter F. W. Bierman, Reinout van Crevel, Andy I. M. Hoepelman, Mark A. A. Claassen, Heidi S. M. Ammerlaan, Berend J. van Welzen, Marjo E. E. van Kasteren, Steven F. L. van Lelyveld, Dorien de Jong, Kiki Tesselaar, Matthijs van Luin, Monique Nijhuis, Annemarie M. J. Wensing, LOWERIT Study Team
Publikováno v: Viruses, Vol 16, Iss 2, p 182 (2024)
There is an ongoing debate regarding whether low-level viremia (LLV), in particular persistent LLV, during HIV treatment with optimal adherence originates from low-level viral replication, viral production, or both. We performed an observational stud
Externí odkaz: https://doaj.org/article/f26c5e2ea53642dd922ae0760c7e8299
Zobrazit plný text záznamu
2
8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)
Autor: Bart van Hoek, Bart J. A. Rijnders, Joop E. Arends, Anthonius S. M. Dofferhoff, Marjo E. E. van Kasteren, Guido E.L. van den Berk, Marc van der Valk, Dirk Posthouwer, Thomas Vanwolleghem, Dewkoemar Ramsoekh, Janke Schinkel, Anne Boerekamps, Jelle Koopsen, Eric Florence
Publikováno v: Journal of hepatology, 70(3), 554-557. Elsevier
Journal of Hepatology, 70(3), 554-557
Boerekamps, A, Vanwolleghem, T, van der Valk, M, van den Berk, G E, van Kasteren, M, Posthouwer, D, Dofferhoff, A S M, van Hoek, B, Ramsoekh, D, Koopsen, J, Schinkel, J, Florence, E, Arends, J E & Rijnders, B J 2019, ' 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study) ', Journal of Hepatology, vol. 70, no. 3, pp. 554-557 . https://doi.org/10.1016/j.jhep.2018.10.032
Journal of Hepatology, 70(3), 554-557. Elsevier
Journal of hepatology
Journal of Hepatology, 70(3), 554-557. Elsevier Science
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4e67bcdb709cf516cf21f3184a1e2f
http://www.scopus.com/inward/record.url?scp=85060958739&partnerID=8YFLogxK
Zobrazit plný text záznamu
3
[COVID-19: patient zero in the Netherlands]
Autor: Christian E A, Alderweireld, Anton G M, Buiting, Jean-Luc A N, Murk, Jaco J, Verweij, Marvin A H, Berrevoets, Marjo E E, van Kasteren
Publikováno v: Nederlands tijdschrift voor geneeskunde. 164
Since December 2019, the world is captivated by SARS-CoV-2, a new coronavirus that shows a lot of similaritieswith previous coronaviruses such as SARS and MERS. Although it was initially seen mainly in China and the surrounding countries, now it also
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::747c3ad0580e7e19ae7d916ee8227e7c
https://pubmed.ncbi.nlm.nih.gov/32613784
Zobrazit plný text záznamu
4
Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy
Autor: Eliane M. S. Leyten, Ferdinand W. N. M. Wit, Casper Rokx, Anneloes M Postma, Andy I. M. Hoepelman, Marjo E. E. van Kasteren, Ingeborg E A Wijting, Ghariba Bouchtoubi, Vera C M Bloemen, Kees Brinkman, Bart J. A. Rijnders, Marchina E. van der Ende, Peter Reiss, Wouter F W Bierman, Selwyn H. Lowe
Publikováno v: EClinicalMedicine
EClinicalMedicine, 17:100210. Lancet Publishing Group
EClinicalMedicine, 17:100210. Elsevier
EClinicalMedicine, Vol 17, Iss, Pp-(2019)
EClinicalMedicine, 17. Elsevier
Background: Integrase inhibitors (INI) induce a rapid decline of HIV-RNA in plasma and CD4+ T-cell recovery in blood. Both characteristics are also associated with immune reconstitution inflammatory syndrome (IRIS). Whether the use of INI-containing
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c499d532107a80a8b99a7469894064c
https://doi.org/10.1016/j.eclinm.2019.11.003
Zobrazit plný text záznamu
5
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy
Autor: Mark A. A. Claassen, Bart J. A. Rijnders, Stephanie Popping, Corine E Delsing, D. W. M. Verhagen, Anton S M Dofferhoff, Charles A. Boucher, Dirk Posthouwer, Marjo E. E. van Kasteren, Wouter F W Bierman, Arne van Eeden, Joop E. Arends, David A. M. C. van de Vijver, Robert Soetekouw, Paul H. P. Groeneveld, Edgar J G Peters, Kamilla D. Lettinga, Sebastiaan J. Hullegie, Eliane M. S. Leyten, Guido E.L. van den Berk, F. N. Lauw, Anne Boerekamps, Frank P. Kroon
Publikováno v: Boerekamps, A, van den Berk, G E, Lauw, F N, Leyten, E M, van Kasteren, M E, van Eeden, A, Posthouwer, D, Claassen, M A, Dofferhoff, A S, Verhagen, D W M, Bierman, W F, Lettinga, K D, Kroon, F P, Delsing, C E, Groeneveld, P H, Soetekouw, R, Peters, E J, Hullegie, S J, Popping, S, van de Vijver, D A M C, Boucher, C A, Arends, J E & Rijnders, B J 2018, ' Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy ', Clinical Infectious Diseases, vol. 66, no. 9, pp. 1360-1365 . https://doi.org/10.1093/cid/cix1007, https://doi.org/10.1093/cid/cix1007
Clinical Infectious Diseases, 66(9), 1360-1365
Clinical Infectious Diseases, 66(9), 1360-1365. Oxford University Press
Clinical Infectious Diseases, 66, 1360-1365
Clinical Infectious Diseases, 66, 9, pp. 1360-1365
Background. Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infected patients. Modeling studies predict that universal HCV treatment will lead to a decrease in the incidence of new infections but real-life data are l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b294746e56b813219ab13936a335d4a1
https://research.vumc.nl/en/publications/15cccc8b-4443-422a-841b-61ca5f1ba21e
Zobrazit plný text záznamu
6
The Value of F-18-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever
Autor: Marjolijn C.A. Wegdam-Blans, Ilse J.E. Kouijzer, Peter C. Wever, Marjo E. E. van Kasteren, Heidi S. M. Ammerlaan, Lioe-Fee de Geus-Oei, Jacqueline Buijs, L. M. Kampschreur, Monique G.L. de Jager-Leclercq, Chantal P. Bleeker-Rovers, Corneline J. Hoekstra, Wim J.G. Oyen, Marrigje H. Nabuurs-Franssen
Publikováno v: The Journal of Nuclear Medicine (1978), 59, 1, pp. 127-133
The Journal of nuclear medicine, 59(1), 127-133. Society of Nuclear Medicine Inc.
The Journal of Nuclear Medicine (1978), 59, 127-133
Journal of Nuclear Medicine, 59(1), 127-133
In 1%–5% of all acute Q fever infections, chronic Q fever develops, mostly manifesting as endocarditis, infected aneurysms, or infected vascular prostheses. In this study, we investigated the diagnostic value of 18F-FDG PET/CT in chronic Q fever at
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334bf48c031345edf15288bb42348b47
https://doi.org/10.2967/jnumed.117.192492
Zobrazit plný text záznamu
7
Chronic Q Fever Diagnosis—Consensus Guideline versus Expert Opinion
Autor: Linda M, Kampschreur, Marjolijn C A, Wegdam-Blans, Peter C, Wever, Nicole H M, Renders, Corine E, Delsing, Tom, Sprong, Marjo E E, van Kasteren, Henk, Bijlmer, Daan, Notermans, Jan Jelrik, Oosterheert, Frans S, Stals, Marrigje H, Nabuurs-Franssen, Chantal P, Bleeker-Rovers, Leo G, Visser
Publikováno v: Emerging Infectious Diseases, Vol 21, Iss 7, Pp 1183-1188 (2015)
Emerging Infectious Diseases
Emerging Infectious Diseases, 21, 7, pp. 1183-8
Emerging Infectious Diseases, 21, 1183-8
Emerging Infectious Diseases, 21(7), 1183. Centers for Disease Control and Prevention (CDC)
Literature-based consensus guideline is more sensitive and easier to use in clinical practice.
Chronic Q fever, caused by Coxiella burnetii, has high mortality and morbidity rates if left untreated. Controversy about the diagnosis of this comple
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8609381540e4c7fea96396d666aa7900
https://wwwnc.cdc.gov/eid/article/21/7/13-0955_article
Zobrazit plný text záznamu
8
The Value of
Autor: Ilse J E, Kouijzer, Linda M, Kampschreur, Peter C, Wever, Corneline, Hoekstra, Marjo E E, van Kasteren, Monique G L, de Jager-Leclercq, Marrigje H, Nabuurs-Franssen, Marjolijn C A, Wegdam-Blans, Heidi S M, Ammerlaan, Jacqueline, Buijs, Lioe-Fee de, Geus-Oei, Wim J G, Oyen, Chantal P, Bleeker-Rovers
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 59(1)
In 1%-5% of all acute Q fever infections, chronic Q fever develops, mostly manifesting as endocarditis, infected aneurysms, or infected vascular prostheses. In this study, we investigated the diagnostic value of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a1c5b1d5cc9ac38e0def56efc1a6b367
https://pubmed.ncbi.nlm.nih.gov/28546336
Zobrazit plný text záznamu
10
Microbiological challenges in the diagnosis of chronic Q fever
Autor: Marrigje H. Nabuurs-Franssen, Cornelis A. R. Groot, Monique G.L. de Jager-Leclercq, Chantal P. Bleeker-Rovers, Jan Jelrik Oosterheert, Marjo E. E. Van Kasteren, Yvonne E. P. Soethoudt, Tom Sprong, Corine E Delsing, Peter C. Wever, Marjolijn C.A. Wegdam-Blans, Sybrandus N. Blank, Andy I. M. Hoepelman, Marjolijn J. H. Pronk, Rolf H.H. Groenwold, Annemarie M. C. Koop, Linda M. Kampschreur, Nicole H. M. Renders
Publikováno v: Clinical and Vaccine Immunology, 19, 787-90
Clinical and Vaccine Immunology, 19, 5, pp. 787-90
Diagnosis of chronic Q fever is difficult. PCR and culture lack sensitivity; hence, diagnosis relies mainly on serologic tests using an immunofluorescence assay (IFA). Optimal phase I IgG cutoff titers are debated but are estimated to be between 1:80
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969056a4057f5c5a937a0105a81e0f1e
https://hdl.handle.net/2066/108667
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje